The prevalence of diabetes mellitus worldwide is increasing, in part due to an obesity epidemic. Thus, prevention and treatment of vision loss from diabetic retinopathy, including proliferative diabetic retinopathy and diabetic macular edema (DME), has become more important.1 Diabetic macular edema, a swelling of the central part of the macula (Figure), affects approximately 746 000 adults aged 40 years or older in the United States (approximately 4% with diabetes develop DME).2
Jampol LM, Bressler NM, Glassman AR. Revolution to a New Standard Treatment of Diabetic Macular Edema. JAMA. 2014;311(22):2269–2270. doi:10.1001/jama.2014.2536
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: